Results 1 to 10 of about 1,034,952 (285)
Hyperthermic Intraperitoneal Chemotherapy: A Critical Review [PDF]
Cancers, 2021 With increasing awareness amongst physicians and improved radiological imaging techniques, the peritoneal cavity is increasingly recognized as an important metastatic site in various malignancies. Prognosis of these patients is usually poor as traditional treatment including surgical resection or systemic treatment is relatively ineffective ...
Wim Ceelen +2 more
openaire +7 more sources
Hyperthermic Intraperitoneal Chemotherapy in Ovarian Cancer [PDF]
New England Journal of Medicine, 2018 (Abstracted from N Engl J Med 2018;378:230–240) The majority of patients with ovarian cancer (OC) receive an initial diagnosis of advanced disease that has spread from the ovaries to the peritoneal surface. The most effective treatment for patients with advanced disease is cytoreductive surgery followed by systemic chemotherapy.
Ceresoli, M, Frigerio, L, Ansaloni, L
semanticscholar +20 more sources
Intraperitoneal Chemotherapy of Ovarian Cancer [PDF]
Women's Health, 2007 Ovarian cancer is the leading cause of death among cancers of the female reproductive tract. Most women present with regionally advanced intraperitoneal disease with superficial spread of tumor along the peritoneal surfaces. Distant metastasis rarely occurs until late in the disease process; however, long-term survival of patients with advanced ...
Robert J Morgan, Thomas Lowe
openaire +3 more sources
Journal of gastrointestinal oncology, 2016 Peritoneal spread of tumors is a major problem in cancer management. Patients develop a marked deterioration in quality of life and shortened survival. This is in part due to bowel obstructions, marked ascites, and overall increase debilitation. Standard medical management has shown to be inadequate for the treatment of these problems.
Sarah J. McPartland +3 more
openaire +3 more sources
International Journal of Gynecological Cancer, 2010 Critical evaluation of the benefits of intraperitoneal (IP) chemotherapy.Critical review of the literature in support of the administration of chemotherapy via the IP route.The 3 largest randomized phase III trials conducted by the Gynecologic Oncology Group and published over a 10-year period clearly demonstrated a 19% to 25% reduction in risk of ...
openaire +3 more sources
Ovarialkarzinom: Chemotherapie intraperitoneal? [PDF]
Im Focus Onkologie, 2015 Die intraperitoneale Applikation der Chemotherapie bei fortgeschrittenem Ovarialkarzinom wird nicht routinemasig eingesetzt. Anhand gepoolter Daten der GOG (Gynecologic Oncology Group) wurde der Langzeiterfolg uberpruft.
openaire +2 more sources
Anesthetic implications in hyperthermic intraperitoneal chemotherapy
Journal of Anaesthesiology Clinical Pharmacology, 2019 Patients with peritoneal carcinomatosis were considered incurable with dismal survival rates till hyperthermic intraperitoneal chemotherapy after optimal cytoreductive surgery evolved. Perioperative management for these procedures is complex and involves an optimal cytoreductive surgery followed by hyperthermic intraperitoneal chemotherapy.
Sachidanand Jee Bharti +5 more
openaire +3 more sources
Effect of hyperthermic intraperitoneal chemotherapy on thrombin generation and fibrinolysis. [PDF]
Int J Colorectal DisLundbech M +4 more
europepmc +1 more source
Intraperitoneal chemotherapy is now back for ovarian cancer. [PDF]
Int J Clin OncolFujiwara K, Nagao S, Tan D, Hasegawa K.
europepmc +1 more source